
Jan 22 (Reuters) - Johnson & Johnson JNJ.N:
JNJ Q4 ADJUSTED EPS $2.04 VERSUS IBES ESTIMATE $2.01
JNJ Q4 SALES $22.52 BILLION VERSUS IBES ESTIMATE $22.42 BILLION
JNJ Q4 STELARA SALES $2.35 BILLION
JNJ Q4 DARZALEX SALES $3.08 BILLION
JNJ OUTLOOK FY ADJUSTED EPS $10.75 TO $10.95 VERSUS IBES ESTIMATE $10.56
JNJ OUTLOOK FY OPERATIONAL SALES $90.9 BILLION TO $91.7 BILLION VERSUS IBES ESTIMATE $90.98 BILLION
Source text: [ID:]
Further company coverage: JNJ.N
((Reuters.Briefs@thomsonreuters.com))